CX Daily: China’s Money-Losing IPO Fever Breaks

IPO /

China’s money-losing IPO fever breaks

For more than a year, not a single IPO application from a money-losing company has been accepted by China’s two largest stock exchanges, a sign that regulators have slowed the pace of such new listings.

The last unprofitable company to see its IPO application accepted was Chongqing Genrix Biopharmaceutical Co. Ltd. on June 20, 2022. The company debuted on the Shanghai Stock Exchange’s Nasdaq-style STAR Market a year later.